Cite
HARVARD Citation
Vorobyev, V. et al. (n.d.). P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN-LABEL, 2-ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL). HemaSphere. pp. 1013-1014. [Online].